Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.
副流感病毒 5 (PIV5) 载体鼻内 COVID-19 疫苗作为单剂量启动剂和加强剂对抗 SARS-CoV-2 变种的功效
期刊:Journal of Virology
影响因子:3.8
doi:10.1128/jvi.01989-24
Beavis Ashley C, Li Zhuo, Briggs Kelsey, Gingerich MarÃa Cristina, Wrobel Elizabeth R, Najera Maria, An Dong, Orr-Burks Nichole, Murray Jackelyn, Patil Preetish, Huang Jiachen, Mousa Jarrod, Hao Linhui, Hsiang Tien-Ying, Gale Michael Jr, Harvey Stephen B, Tompkins S Mark, Hogan Robert Jeffrey, Lafontaine Eric R, Jin Hong, He Biao